Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Masimo (MASI) Short term Debt (2013 - 2016)

Masimo's quarterly Short term Debt came in at $75000.0 in Q3 2016, down 6.25% year-on-year from $80000.0 in Q3 2015, and down 1.32% quarter-over-quarter from $76000.0 in Q2 2016.

Masimo has reported Short term Debt for 4 years, with the latest figure at $75000.0 in Q3 2016.

  • For the quarter ending Q3 2016, Short term Debt fell 6.25% year-over-year to $75000.0; the trailing twelve-month figure through Jul 2016 stood at $75000.0 (down 6.25% YoY), and the FY2016 full-year result was $74000.0, down 6.33% from the prior year.
  • Short term Debt for Q3 2016 stood at $75000.0, down from $76000.0 in the prior quarter.
  • The five-year high for Short term Debt was $125.1 million in Q3 2014, with the low at $74000.0 in Q1 2016.
  • Average Short term Debt over 4 years is $20.1 million, with a median of $80000.0 recorded in 2015.
  • Year-over-year, Short term Debt plunged 99.94% in 2015 and slipped 6.25% in 2016.
  • Tracing MASI's Short term Debt over 4 years: stood at $111000.0 in 2013, then surged by 112587.39% to $125.1 million in 2014, then sank by 99.94% to $80000.0 in 2015, then fell by 6.25% to $75000.0 in 2016.
  • The last three Short term Debt figures came in at $75000.0 (Q3 2016), $76000.0 (Q2 2016), and $74000.0 (Q1 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Masimo 9.32 Bn 9.20 Bn 250.80 Mn

Historic Data

Download Data 🔒
DateValue
Jul 2, 2016 75,000.00
Apr 2, 2016 76,000.00
Jan 2, 2016 74,000.00
Oct 3, 2015 80,000.00
Jul 4, 2015 80,000.00
Apr 4, 2015 84,000.00
Jan 3, 2015 79,000.00
Sep 27, 2014 125.08 Mn
Jun 28, 2014 75.09 Mn
Dec 28, 2013 111,000.00